JP2015086183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015086183A5 JP2015086183A5 JP2013226750A JP2013226750A JP2015086183A5 JP 2015086183 A5 JP2015086183 A5 JP 2015086183A5 JP 2013226750 A JP2013226750 A JP 2013226750A JP 2013226750 A JP2013226750 A JP 2013226750A JP 2015086183 A5 JP2015086183 A5 JP 2015086183A5
- Authority
- JP
- Japan
- Prior art keywords
- administration
- hours
- mmp
- sustained release
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000969 carrier Substances 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 102100018200 MMP1 Human genes 0.000 description 4
- 101700019781 MMP1 Proteins 0.000 description 4
- 230000002459 sustained Effects 0.000 description 4
- 210000003491 Skin Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003111 delayed Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002353 niosome Substances 0.000 description 1
Description
近赤外線ダメージ抑制剤は、近赤外線照射後一定期間経過後のＭＭＰ−１発現亢進を抑えるものであればよく、例えば、前述の紫外線ダメージ抑制剤のようなＭＭＰ−１発現阻害剤を徐放性担体に含めてもよい。
徐放性担体は、含まれるＭＭＰ−１発現阻害剤を遅れて放出できるものであればよく、通常投与後２４時間後まで、好ましくは投与後３０時間後まで、より好ましくは投与後３６時間後まで、さらに好ましくは投与後４２時間後、特に好ましくは投与後４８時間後にまで、含有するＭＭＰ−１発現阻害剤を放出できればよい。
NIR damage inhibitor, as long as it suppresses the MMP-1 expression increased after lapse after NIR irradiation period of time, for example, - release the MMP-1 expression inhibitors such as UV damage inhibitors described above It may be included in the carrier.
Sustained release carrier may be used as long as it can release delayed the MMP-1 expression inhibitor included, usually up to 24 hours after administration, preferably up to 30 hours after administration, more preferably 36 hours after administration It is sufficient that the contained MMP-1 expression inhibitor can be released until 42 hours after administration, more preferably 48 hours after administration.
徐放性担体としては、皮膚外用剤に用いられる徐放性担体や食品に用いられる徐放性担体が適宜用いられ、具体的にはリポソーム、ニオソーム、マイクロカプセル等が挙げられる。 The sustained release carrier is used as appropriate sustained release carrier used sustained release carrier and food used in the skin external agent, in particular a liposome, niosomes, microcapsules and the like.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013226750A JP6305727B2 (en) | 2013-10-31 | 2013-10-31 | Skin photoaging prevention composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013226750A JP6305727B2 (en) | 2013-10-31 | 2013-10-31 | Skin photoaging prevention composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015086183A JP2015086183A (en) | 2015-05-07 |
| JP2015086183A5 true JP2015086183A5 (en) | 2016-10-27 |
| JP6305727B2 JP6305727B2 (en) | 2018-04-04 |
Family
ID=53049360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013226750A Active JP6305727B2 (en) | 2013-10-31 | 2013-10-31 | Skin photoaging prevention composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6305727B2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6908968B2 (en) * | 2016-02-12 | 2021-07-28 | ピアス株式会社 | Topical skin anti-wrinkle agent and sRAGE production promoter in fibroblasts |
| JP2017171655A (en) * | 2016-03-17 | 2017-09-28 | 大塚製薬株式会社 | Skin external composition for blocking near infrared radiation |
| KR102348047B1 (en) * | 2016-07-29 | 2022-01-10 | (주)아모레퍼시픽 | Composition comprising peach sprout extract for inhibiting secretion of sebum |
| CN106860120B (en) * | 2017-04-07 | 2020-09-29 | 美晨集团股份有限公司 | Anti-aging composition, preparation method and application thereof |
| KR102418101B1 (en) * | 2017-11-30 | 2022-07-08 | (주)아모레퍼시픽 | Composition for preventing or alleviating intrinsic aging comprising paeoniflorin or albiflorin |
| CN111840301A (en) * | 2019-04-24 | 2020-10-30 | 太阳星光齿磨公司 | Application of gamma-oryzanol and application of liposome containing gamma-oryzanol |
| JP2020180070A (en) * | 2019-04-25 | 2020-11-05 | サンスター株式会社 | Anti-skin aging composition for external use |
| JP6818927B2 (en) * | 2020-07-30 | 2021-01-27 | サンスター株式会社 | Anti-skin aging topical composition |
| CN117224436B (en) * | 2023-11-07 | 2024-01-26 | 成都乾坤动物药业股份有限公司 | Extraction method of sun-proof component of pteridophyte |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04124138A (en) * | 1990-09-05 | 1992-04-24 | Beijin Riiyuen Riiyon Fuashiyue Guufuen Youshien Gonsuu | External preparation for skin |
| JPH07157412A (en) * | 1993-12-03 | 1995-06-20 | Kuga Takaaki | Cosmetic |
| JPH09131393A (en) * | 1995-11-10 | 1997-05-20 | Shiseido Co Ltd | Deodorant, deodorizing composition, and deodorizing cosmetic |
| JPH1072336A (en) * | 1996-06-28 | 1998-03-17 | Kao Corp | Collagen gel contraction accelerator |
| JP2000154132A (en) * | 1998-11-19 | 2000-06-06 | Shiseido Co Ltd | Antiaging agent |
| US6335023B1 (en) * | 1999-06-30 | 2002-01-01 | Ruey J. Yu | Oligosaccharide aldonic acids and their topical use |
| JP2001086954A (en) * | 1999-09-20 | 2001-04-03 | Yakult Honsha Co Ltd | Health drink or food |
| JP2003095912A (en) * | 2001-09-20 | 2003-04-03 | Noevir Co Ltd | Skin care preparation |
| JP2003183122A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Agent for inhibiting activity of collagenase |
| JP2003192528A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003192565A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| KR101095258B1 (en) * | 2002-12-19 | 2011-12-20 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | Method for keeping the level of moisture in compositions and uses thereof |
| JP2006523684A (en) * | 2003-04-15 | 2006-10-19 | シトラメッド リミテッド | Composition containing activated citrus peel extract |
| FR2858932B1 (en) * | 2003-08-22 | 2009-10-30 | Oreal | COMPOSITION FOR CONTROLLING THE DEGRADATION OF INDUCED COLLAGEN FIBERS IN NATURAL SOLAR EXPOSURE CONDITIONS |
| JP2005306746A (en) * | 2004-04-19 | 2005-11-04 | Jiyugaoka Clinic | Wrinkle therapeutic agent for face |
| TWI342780B (en) * | 2004-08-11 | 2011-06-01 | Access Business Group Int Llc | Dietary supplement |
| JP2006076910A (en) * | 2004-09-09 | 2006-03-23 | Ichimaru Pharcos Co Ltd | Cyclooxygenase activity inhibitor |
| JP4634769B2 (en) * | 2004-10-04 | 2011-02-16 | 独立行政法人産業技術総合研究所 | Whitening effect improver, method for producing the same, whitening composition using the same, and external preparation for skin containing the same |
| CA2644664C (en) * | 2006-03-09 | 2016-05-03 | The University Of British Columbia | Methods of treating, reducing and inhibiting the appearance of ageing in the skin |
| JP5740072B2 (en) * | 2007-03-05 | 2015-06-24 | ダイソー株式会社 | Stress relieving agent using β-1,3-1,6-D-glucan |
| JP2013511515A (en) * | 2009-11-20 | 2013-04-04 | 株式会社アモーレパシフィック | Cosmetic composition containing inorganic powder |
| JP2011162513A (en) * | 2010-02-12 | 2011-08-25 | Sunny Place:Kk | Pomegranate seed extract, pharmaceutical composition, food and drink, and cosmetic thereof, and method for use thereof |
| KR101080186B1 (en) * | 2010-06-21 | 2011-11-07 | 주식회사 필라이트솔루션 | Improved led lamp |
| JP5791879B2 (en) * | 2010-06-22 | 2015-10-07 | 三省製薬株式会社 | NF-κB activation inhibitor and pore care agent |
| JP2012056933A (en) * | 2010-09-13 | 2012-03-22 | Maruzen Pharmaceut Co Ltd | Elastin production promoter |
| JP6266857B2 (en) * | 2010-09-21 | 2018-01-24 | 共栄化学工業株式会社 | Cosmetics |
| JP2011055837A (en) * | 2010-10-25 | 2011-03-24 | Maruzen Pharmaceut Co Ltd | Food and drink for beautification |
| JP6029284B2 (en) * | 2012-02-14 | 2016-11-24 | 一丸ファルコス株式会社 | Kinesin inhibitors |
-
2013
- 2013-10-31 JP JP2013226750A patent/JP6305727B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015086183A5 (en) | ||
| HK1248235A1 (en) | Benzimidazole and imadazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase | |
| HK1219734A1 (en) | Bcl-2bcl-xl inhibitors and therapeutic methods using the same bcl-2/bcl-xl | |
| HK1218110A1 (en) | Sulfamoyl arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
| HK1222297A1 (en) | Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof ampk | |
| IL238876A0 (en) | Indoleamine 2,3-dioxygenase inhibitors, compositions comprising the same and uses thereof | |
| GB2513167B (en) | Tetrahydrocannabivarin for use in the treatment of nausea and vomiting | |
| IL271352B (en) | Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases | |
| EP3452451A4 (en) | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | |
| IL244920B (en) | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | |
| PL3004108T3 (en) | Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease | |
| IL252828A0 (en) | Piperidine derivative hdac1/2 inhibitor compounds, compositions comprising same and uses thereof | |
| EP2947070A4 (en) | Multi-targeted ubenimex prodrug derivative and preparation method and use thereof | |
| HK1221875A1 (en) | Use of a composition comprising fish oil and juice for the treatment of inflammation | |
| ZA201200608B (en) | L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin | |
| EP2999346A4 (en) | Treatment of potatoes and root vegetables during storage | |
| EP3452452A4 (en) | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | |
| EP3454653A4 (en) | Cryopreservation medium and method to prevent recrystallization | |
| EP2575842A4 (en) | A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases | |
| EP3730484C0 (en) | Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor, and application thereof | |
| GB2583606C (en) | Indoleamine 2,3-Dioxygenase inhibitors and use of same in medicine | |
| PL3052139T3 (en) | Pre-saturation of the liver and subsequent administration of the contrast agent | |
| PH12016502059B1 (en) | Fast dissolving granulate | |
| EP3065548A4 (en) | Fibrosis inhibiting compounds and methods of use thereof in the prevention or treatment of fibrosing diseases | |
| WO2014124059A3 (en) | Inhibitors of hemeprotein-catalyzed lipid peroxidation |